Trial Profile
Comparative evaluation of the effects of treatment with tocilizumab and TNF-alpha inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Tumour necrosis factor alpha inhibitors
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 17 Dec 2015 New trial record